Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis (QUASAR): Phase 3 Double-Blind, Randomised, Placebo-Controlled Induction and Maintenance Studies
Population-Health Impact of New Drugs Recommended by the National Institute for Health and Care Excellence in England During 2000–20: A Retrospective Analysis